Publication:
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections

1

Issued Date

2014-01-01

Resource Type

Article

ISSN

10986596
00664804

DOI

10.1128/AAC.02435-13

Other identifier(s)

2-s2.0-84906080468

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Antimicrobial Agents and Chemotherapy. Vol.58, No.9 (2014), 5598-5601

Suggested Citation

Rujipas Sirijatuphat, Visanu Thamlikitkul Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrobial Agents and Chemotherapy. Vol.58, No.9 (2014), 5598-5601. doi:10.1128/AAC.02435-13 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/34603

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections

Author(s)

Rujipas Sirijatuphat
 Visanu Thamlikitkul

Other Contributor(s)

Mahidol University

Abstract

Ninety-four patients infected with carbapenem-resistant Acinetobacter baumannii were randomized to receive colistin alone or colistin plus fosfomycin for 7 to 14 days. The patients who received combination therapy had a significantly more favorable microbiological response and a trend toward more favorable clinical outcomes and lower mortality than those who received colistin alone. (This study has been registered at ClinicalTrials.gov under registration no. NCT01297894.) Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Keyword(s)

Medicine
 Pharmacology, Toxicology and Pharmaceutics

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/34603

Collections

Scopus 2011-2015